3-FPM Stats & Data

3-FPM is a phenmetrazine analogue; like phenmetrazine it appears to act primarily on dopamine and norepinephrine systems with minimal direct serotonin releasing activity reported, which lowers—but does not eliminate—serotonin syndrome concerns when used alone. However, cardiovascular and neurobehavioral risks typical of stimulants still apply, especially with redosing. Erowid and community reports emphasize strong 'more-ish' qualities and that vaped or insufflated routes are particularly compulsive; pre-planning maximum total dose and avoiding short-interval redoses can reduce harms. Nasal administration is notably caustic and can acutely damage mucosa; if used, finely crush, keep lines small, alternate nostrils, rinse with sterile saline before/after, and allow multi‑day healing intervals to prevent erosions or septal injury. Batch-to-batch variability and adulteration have been reported; where available, use a certified drug checking service and be skeptical of off‑white/pink or gritty material, unexpected residues on heating, or weak effects at typical doses. Combining with alcohol or other stimulants meaningfully increases heart rate, blood pressure, and vasoconstriction; this can raise risks of chest pain, palpitations, and overheating—avoid such mixes and monitor exertion and ambient temperature. Hydration and nutrition matter: sip water regularly (about 250 ml per hour at rest, up to 500 ml per hour if active) and include electrolytes after several hours; eat a balanced meal before use to mitigate appetite suppression and comedown fatigue. Sleep debt strongly worsens anxiety and low mood on the comedown; plan sufficient sleep opportunity, and avoid consecutive‑day use to limit tolerance and compulsion. Pharmacokinetic data for 3‑FPM are sparse; phenmetrazine (the parent drug) has a long half‑life (16–31 h), but 3‑FPM subjectively feels shorter; residual stimulation into the next day can still occur after high or repeated dosing. Given variable market quality, be alert for unexpected effects (e.g., unusual sedation or very long duration) that may indicate mislabeling or cuts; discontinue and consider checking the sample if this occurs. People with hypertension, arrhythmias, cardiovascular disease, or significant anxiety disorders should avoid use or seek medical guidance; stimulants increase cardiac workload and can exacerbate anxiety and bruxism.